METROPOLISHealthcare Service Provider
Metropolis Healthcare Ltd — Profit & Loss Statement
₹434.00
-1.82%
Metropolis Healthcare Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 1.54 Cr | 0.30 Cr | 0.11 Cr | 4.31 Cr | — |
| Tax Rate For Calcs | 0.24 | 0.26 | 0.24 | 0.27 | — |
| Normalized EBITDA | 311.64 Cr | 290.57 Cr | 303.03 Cr | 360.04 Cr | — |
| Total Unusual Items | 6.46 Cr | 1.12 Cr | 0.49 Cr | 16.28 Cr | — |
| Total Unusual Items Excluding Goodwill | 6.46 Cr | 1.12 Cr | 0.49 Cr | 16.09 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 144.97 Cr | 127.82 Cr | 142.88 Cr | 214.18 Cr | — |
| Reconciled Depreciation | 108.68 Cr | 94.47 Cr | 89.22 Cr | 63.22 Cr | — |
| Reconciled Cost Of Revenue | 283.40 Cr | 260.72 Cr | 263.69 Cr | 287.30 Cr | — |
| Selling And Marketing Expense | 37.95 Cr | 32.77 Cr | 26.16 Cr | 26.93 Cr | — |
| General And Administrative Expense | 148.23 Cr | 132.76 Cr | 132.44 Cr | 147.40 Cr | — |
| Rent And Landing Fees | 128.12 Cr | 105.26 Cr | 94.10 Cr | 105.67 Cr | — |
| Gross Profit | 1.05K Cr | 946.99 Cr | 884.52 Cr | 941.02 Cr | — |
| Cost Of Revenue | 283.40 Cr | 260.72 Cr | 263.69 Cr | 287.30 Cr | — |
| Total Revenue | 1.33K Cr | 1.21K Cr | 1.15K Cr | 1.23K Cr | — |
| Operating Revenue | 1.33K Cr | 1.21K Cr | 1.15K Cr | 1.23K Cr | — |
| EBITDA | 318.11 Cr | 291.69 Cr | 303.52 Cr | 376.32 Cr | — |
| EBIT | 209.43 Cr | 197.22 Cr | 214.30 Cr | 313.09 Cr | — |
| Net Interest Income | -20.38 Cr | -24.63 Cr | -26.14 Cr | -13.88 Cr | — |
| Interest Expense | 18.57 Cr | 22.54 Cr | 26.80 Cr | 19.74 Cr | — |
| Interest Income | 3.51 Cr | 3.26 Cr | 5.71 Cr | 11.15 Cr | — |
| Normalized Income | 140.04 Cr | 126.99 Cr | 142.51 Cr | 202.59 Cr | — |
| Net Income From Continuing And Discontinued Operation | 144.97 Cr | 127.82 Cr | 142.88 Cr | 214.18 Cr | — |
| Total Expenses | 1.13K Cr | 1.00K Cr | 939.39 Cr | 939.51 Cr | — |
| Rent Expense Supplemental | 128.12 Cr | 105.26 Cr | 94.10 Cr | 105.67 Cr | — |
| Diluted Average Shares | 5.15 Cr | 5.14 Cr | 5.14 Cr | 5.14 Cr | — |
| Basic Average Shares | 5.13 Cr | 5.12 Cr | 5.12 Cr | 5.12 Cr | — |
| Diluted EPS | 28.15 | 24.87 | 27.81 | 41.66 | — |
| Basic EPS | 28.29 | 24.95 | 27.91 | 41.87 | — |
| Diluted NI Availto Com Stockholders | 144.97 Cr | 127.82 Cr | 142.88 Cr | 214.18 Cr | — |
| Net Income Common Stockholders | 144.97 Cr | 127.82 Cr | 142.88 Cr | 214.18 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 144.97 Cr | 127.82 Cr | 142.88 Cr | 214.18 Cr | — |
| Minority Interests | -0.55 Cr | -0.64 Cr | -0.51 Cr | -0.50 Cr | — |
| Net Income Including Noncontrolling Interests | 145.51 Cr | 128.46 Cr | 143.39 Cr | 214.69 Cr | — |
| Net Income Continuous Operations | 145.51 Cr | 128.46 Cr | 143.39 Cr | 214.69 Cr | — |
| Tax Provision | 45.34 Cr | 46.23 Cr | 44.11 Cr | 78.67 Cr | — |
| Pretax Income | 190.85 Cr | 174.69 Cr | 187.50 Cr | 293.35 Cr | — |
| Other Non Operating Income Expenses | 0.18 Cr | 0.76 Cr | 4.52 Cr | 0.44 Cr | — |
| Special Income Charges | -1.04 Cr | -0.04 Cr | -0.19 Cr | 15.67 Cr | — |
| Other Special Charges | -1.76 Cr | — | -77000.00 | -15.89 Cr | 0.01 Cr |
| Write Off | 2.80 Cr | 0.04 Cr | 0.06 Cr | -62000.00 | — |
| Net Non Operating Interest Income Expense | -20.38 Cr | -24.63 Cr | -26.14 Cr | -13.88 Cr | — |
| Total Other Finance Cost | 5.31 Cr | 5.36 Cr | 5.05 Cr | 5.28 Cr | — |
| Interest Expense Non Operating | 18.57 Cr | 22.54 Cr | 26.80 Cr | 19.74 Cr | — |
| Interest Income Non Operating | 3.51 Cr | 3.26 Cr | 5.71 Cr | 11.15 Cr | — |
| Operating Income | 205.91 Cr | 203.40 Cr | 208.82 Cr | 288.82 Cr | — |
| Operating Expense | 841.89 Cr | 743.59 Cr | 675.70 Cr | 652.21 Cr | — |
| Other Operating Expenses | 103.88 Cr | 101.94 Cr | 80.27 Cr | 75.33 Cr | — |
| Depreciation And Amortization In Income Statement | 108.68 Cr | 94.47 Cr | 89.22 Cr | 63.22 Cr | — |
| Amortization | 25.20 Cr | 15.75 Cr | 14.50 Cr | 11.17 Cr | — |
| Depreciation Income Statement | 83.48 Cr | 78.72 Cr | 74.71 Cr | 52.05 Cr | — |
| Selling General And Administration | 186.17 Cr | 165.53 Cr | 158.59 Cr | 174.33 Cr | — |
| Impairment Of Capital Assets | — | 0.00 | 0.14 Cr | 0.03 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Metropolis Healthcare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.